Celltrion Pharm Inc (068760) — Free Cash Flow Generation Index
Celltrion Pharm Inc (068760) has a Free Cash Flow Generation Index of 0.90x as of September 2025. Free cash flow of ₩21.18 Billion represents 1% of operating cash flow (₩23.44 Billion). Explore 068760 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Celltrion Pharm Inc Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for Celltrion Pharm Inc across 8 annual periods. For the full cash flow conversion analysis, see 068760 cash flow metrics.
Annual Free Cash Flow Generation for Celltrion Pharm Inc (2014–2024)
Year-by-year Free Cash Flow Generation Index for Celltrion Pharm Inc. Check Celltrion Pharm Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.89x | ₩50.61 Billion | ₩56.59 Billion | ₩5.98 Billion | ▲ +321.4% |
| 2023 | 0.21x | ₩1.86 Billion | ₩8.76 Billion | ₩6.90 Billion | ▼ -75.5% |
| 2021 | 0.87x | ₩80.65 Billion | ₩93.15 Billion | ₩12.50 Billion | ▲ +491.9% |
| 2020 | -0.22x | ₩-8.01 Billion | ₩36.25 Billion | ₩41.98 Billion | ▼ -110.5% |
| 2019 | 2.09x | ₩58.34 Billion | ₩27.85 Billion | ₩30.49 Billion | ▲ +39.3% |
| 2018 | 1.50x | ₩21.52 Billion | ₩14.31 Billion | ₩7.21 Billion | ▼ -66.1% |
| 2015 | 4.44x | ₩59.33 Billion | ₩13.36 Billion | ₩45.97 Billion | ▲ +76.9% |
| 2014 | 2.51x | ₩43.48 Billion | ₩17.33 Billion | ₩26.16 Billion | — |